-
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Consensus Rating of "Buy" from Brokerages
来源: Buzz FX / 04 12月 2024 04:36:10 America/Chicago
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Consensus Rating of "Buy" from Brokerages Written by MarketBeat December 4, 2024 Share Link copied to clipboard. Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) has been assigned an
Read more...